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Abstract
Background: Congenital chloride diarrhea (CCD, OMIM 214700) is a rare autosomal recessively inherited condition
characterized by watery diarrhea, hypochloremia and metabolic alkalosis. Mutations of the solute carrier family 26,
member 3 (SLC26A3, OMIM 126650) gene are responsible for the disease. The gene encodes a transmembrane
protein, which is essential for intestinal chloride absorption.
Case presentation: Here we report a Hungarian boy, presenting the clinical phenotype of CCD. The patient born
at 32 weeks of gestation and underwent surgery for abdominal distension and intestinal obstruction related to
malrotation. After recovery, electrolyte replacement therapy was necessary due to several periods of diarrhea. After
exclusion of other possible causes, increased chloride concentration in the feces supported the diagnosis of CCD.
The diagnosis was confirmed by molecular genetic testing. Direct sequencing revealed compound-heterozygosity
for a frameshift mutation c.1295delT (p.Leu432Argfs*11) and the known Polish founder mutation c.2024_
2026dupTCA (p.Ile675_Arg676insLeu).
Conclusions: Here we present the clinical symptoms of the first patient in Hungary diagnosed with CCD. Based on
the clinical symptoms, stool analysis and genetic testing, the diagnosis of CCD was established. Our study provides
expansion for the mutation spectrum of the SLC26A3 gene and the genetic background of CCD.
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Background
Congenital chloride diarrhea (CCD, OMIM 214700) is a
rare congenital diarrhea of autosomal recessive inherit-
ance. The leading symptoms include intrauterine onset
of watery diarrhea, hypokalemia, hypochloremia, hypo-
natremia and metabolic alkalosis. The disorder was first
described in two simultaneous case reports in 1945 [1,
2]. More than 250 cases have been reported since then.
The incidence of CCD is variable worldwide. Most cases
are sporadic; however, CCD occurs more frequently in
Finland, Poland, and in countries around the Persian
Gulf, especially in Kuwait and in Saudi Arabia [3, 4].
The gene for CCD, solute carrier family 26 member 3
(SLC26A3, NM_000111) is located on chromosome
7q22.3-q31.1 [3, 5] and encodes a transmembrane pro-
tein, which is an apical epithelial Cl−/HCO3
− exchanger
expressed on the surface epithelium of the ileum and
colon. The malfunction of this anion transporter results
in deficient absorption of Cl− and secretion of HCO3
−.
So far, more than 70 mutations of the gene – including
the founder mutations from Finland, Poland and Arabic
countries – are known to be pathogenic (http://
www.hgmd.cf.ac.uk). In the present paper, we report the
first discovered case of CCD in Hungary and its genetic
investigation.
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Case presentation
The premature boy, born by Cesarean section at 32
weeks of gestation, had a birthweight of 1850 g and
Apgar scores of 6/1 and 9/5. Prenatal ultrasound was
performed at 24 weeks of gestation and showed small
bowel dilatation of the fetus and increased flow in the
ascending aorta. The newborn had abdominal distension
and had thin, fluid-like discharge from the rectum. Ab-
dominal radiographs showed small bowel ileus (Fig. 1).
On postnatal day 2, laparotomy was performed revealing
a type 1 malrotation of the gut associated with obstruct-
ing Ladd’s Bands. On postnatal day 12, the newborn
developed symptoms of late-onset sepsis caused by Kleb-
siella pneumoniae. Gastrointestinal bleeding, pulmonary
hemorrhage and a small intracranial hemorrhage were
also present. The patient had bilious emesis and failure
to pass stool. Imaging studies showed dilated loops of
the bowel; therefore, detorquation of a bowel loop and
adhesiolysis were performed. After reoperation, he toler-
ated feeding and gained weight; however, repeated blood
analyses indicated hyponatremia, hypochloremia, hypo-
kalemia and metabolic alkalosis, necessitating prolonged
oral electrolyte replacement therapy. Sweat test showed
normal chloride concentrations and direct sequencing of
the coding regions of the cystic fibrosis transmembrane
conductance regulator (CFTR) gene revealed a single
delta F508 mutation. The infant had frequent loose
stools, sometimes 6–10 times per day. In the first
year of life, he was frequently admitted to the hospital
because of viral infections and dehydration, and
needed electrolyte replacement in increasing amounts.
A 24-h urine collection test showed low concentra-
tions of sodium, potassium and chloride ions (9.7
mmol/l, 14.9 mmol/l and 6.6 mmol/l, respectively).
Plasma renin activity (34.2 mg/ml/h) and aldosterone
(51 mg/dl) levels were increased, suggesting secondary
hyperaldosteronism. After exclusion of other possible
causes, chloride loss in the feces was detected. Ele-
vated chloride concentrations were detected in centri-
fuged feces samples (148 and 154 mmol/l; normal
range is below 90 mmol/l) using standard chemistry
analysis. Based on the high chloride levels in the
stool, diagnosis of CCD was established.
To perform molecular genetic confirmation, peripheral
blood samples were drawn from the affected patient and
from his unaffected family members (n = 2), as well as
from unrelated healthy controls (n = 50), and genomic
DNA was isolated from the blood samples. The coding
regions and the flanking introns of the SLC26A3 gene were
amplified and sequenced. Direct sequencing of the investi-
gated regions of the SLC26A3 gene revealed two heterozy-
gous mutations: a novel thymine-base deletion (c.1295delT,
p.Leu432Argfs*11, Fig. 2a) in exon 11 and a recurrent
3-base (TCA) duplication (c.2024_2026dupTCA, p.Ile675
_Arg676insIle, Fig. 2b) in exon 18. After the
disease-causing mutations were identified in the patient,
the mutation status of the parents was determined (Fig. 3).
The clinically unaffected parents carry the mutations in het-
erozygous form, and all unrelated healthy controls (n = 50)
carry the wild type sequence.
After establishing the diagnosis, oral electrolyte sup-
plementation was continued with 2,1 g of NaCl and 2,2 g
of KCl a day, and proton pump-inhibitor therapy was
also administered to inhibit gastric Cl− secretion. [6, 7]
Since then no parenteral fluid replacement therapy was
necessary, as electrolytes were in normal range and al-
kalosis did not recurred. 12 months after the conclusion
of the genetic analysis, the patient has stools still 6–8
times a day, but successfully underwent toilet training.
Currently at the age of 4, his weight is at 25 percentile
(16 kg), his psychomotor development is appropriate for
age, he attends nursery school.
Discussion and conclusions
CCD is a rare autosomal recessive disorder caused by
homozygous and compound heterozygous mutations
of the SLC26A3 gene. The clinical diagnosis is mainly
based on the clinical history, characteristic metabolic
abnormalities and high levels of chloride in stool. The
symptoms and signs frequently overlap with other
Fig. 1 Simple abdominal radiography. Imaging study on the first life
day shows small bowel ileus
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conditions, such as cystic fibrosis and Bartter syn-
drome. Clinical history as well as urinary and sweat
chloride levels help in the differentiation of these dis-
eases (Table 1) [8–10].
Due to absence of known hotspots in the SLC26A3 gene
in the Hungarian population, molecular genetic confirm-
ation of the CCD clinical diagnosis is usually performed
by sequencing the entire coding region of the gene. Most
of the known mutations are point mutations or small
deletions, many of which affect exon 3–6 and 12–15 [10].
In populations in which founder effects have been
observed (Finland, Poland, Saudi Arabia and Kuwait),
single-mutation analysis of the typical founder mutation is
the first test performed [4].
The present case is the first Hungarian patient diag-
nosed with CCD. The condition in the index patient was
caused by compound heterozygous mutations in the
SLC26A3 gene. A novel thymine-base deletion
(c.1295delT, p.Leu432Argfs*11) was identified in exon 11
(Fig. 3a) leading to the development of a premature
termination codon. This newly identified mutation has
not been reported in any SNP database (ExAC, 1000
Genome Project, ESP). The pathogenicity of this novel
variation was suggested by the clinical context and
the fact that the mutation truncates the 3′ half of the
predicted protein. A recurrent 3-base (TCA) duplication
(c.2024_2026dupTCA, p.Ile675_Arg676insIle) was de-
tected in exon 18 (Fig. 3b), resulting in the incorporation
of an additional amino acid into the protein. This recur-
rent disease-causing mutation is a founder mutation in
the Polish population and is involved in almost 50% of the
CCD-associated cases in Poland [4]. Parents of the
reported patient are not aware of any Polish relatives.
Undiagnosed CCD is a severe condition. Only rare
cases are known to have survived after the first year
undiagnosed. In an affected child, an acute gastro-
enteritis can lead to life-threatening dehydration and
hypokalemia. Lifelong electrolyte supplementation to
correct the biochemical abnormalities with NaCl and
KCl is the basis of management. Timely and adequate
therapy determines the outcome, normal growth and
development of the affected child and requires early
Fig. 2 Identification of two mutations of the SLC26A3 gene. Direct sequencing revealed (a) a deletion of a T base (c.1295delT, p.Leu432Argfs*11)
in exon 11 and (b) a duplication of TCA bases (c.2024_2026dupTCA, p.Ile675_Arg676insIle) in exon 18 of the gene. Both mutations were present
in the affected patient in heterozygous state
Fig. 3 Pedigree of the investigated Hungarian patient. The patient
(II/1) was the only clinically affected individual in his pedigree: his
parents (I/1 and I/2) were clinically unaffected
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and sufficient supplementation. Patients require fas-
tidious follow-up to prevent long-term complications,
such as renal failure and hyperuricemia [11]. A cor-
rect diagnosis of CCD has an important impact on
family planning and allows preimplantation genetic
diagnosis and prenatal diagnostics.
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Table 1 Comparison of the clinical phenotype of differential diagnostic disorders
Disorder CCD Bartter syndrome Cystic fibrosis
Characteristic
Onset of disease Presents early in neonates Presents in infants, but can present later Presents primarily in neonates
and infants
Cl− concentration in urine Low High Low
Cl− concentration in stool Elevated in watery stool Not detected in normal stool Not detected in fatty or normal stool
Sweat Cl− test results Can be elevated Normal High
Blood pH Metabolic alkalosis Metabolic alkalosis Metabolic alkalosis
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